ArticleAnnals of surgical oncology2026
A Multidisciplinary Breast Cancer Clinic Improves Time to Treatment at an Urban, Safety Net Hospital.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSocioeconomically vulnerable patients experience significant breast cancer care treatment disparities. Our aim was to examine how multidisciplinary breast cancer clinic (MBCC) implementation affected time to treatment at a safety net hospital.
methodsThis was a retrospective cohort study of female patients (≥18 years) with new breast cancer diagnoses from January 2019-September 2022. Time to treatment from biopsy-confirmed diagnosis was compared between patients seen in MBCC and those in a traditional discipline-based serial episodic clinic model.
resultsAmong 734 patients (mean age 58.5 years), 45.8% identified as Black and 48.4% were insured by Medicaid. MBCC patients (28.9%) were younger (55.7 vs. 59.6 years, P<0.001), less likely to be Hispanic (18.4% vs. 27.6%, P=0.01), more likely to have invasive cancer (86.8% vs. 60.3%, P<0.001), had shorter time to treatment (35.0 vs. 46.9 days, P<0.001), and were more likely to receive chemotherapy first (48.6% vs. 11.5%, P<0.001) compared to non-MBCC patients. In patients who received chemotherapy first, MBCC was associated with reduced time to initial appointment (10.2 vs. 18.1 days, P=0.011) and treatment initiation (27.1 vs. 42.6 days, P<0.001). Multivariable analysis showed invasive histology was associated with MBCC participation (OR 4.29, P<0.0001), while Hispanic ethnicity (OR 0.55, P=0.014) and older age (OR 0.98, P=0.021) were less associated with MBCC.
conclusionsImplementation of a MBCC in a safety net hospital improved time to initial breast cancer treatment for vulnerable patients. Moving forward, MBCC can serve as a model to reduce disparities in vulnerable patient populations.
Indexed as
Identifiers
41107647What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.